C201-0243 is a FcRn antagonist. C201-0243 exhibits antagonistic activity against IgG-FcRn binding with an IC50 of 3.439 nM. C201-0243 can be used in the research of IgG-mediated autoimmune diseases [1].
References:
[1]. Wu G, et al. Virtual Screening Combined with Phase Transition-FRET for Discovery of Small-Molecule FcRn Antagonists. Anal Chem. 2025 May 27;97(20):10661-10670.
References:
[1]. Wu G, et al. Virtual Screening Combined with Phase Transition-FRET for Discovery of Small-Molecule FcRn Antagonists. Anal Chem. 2025 May 27;97(20):10661-10670.
















